XML 53 R42.htm IDEA: XBRL DOCUMENT
v3.8.0.1

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Dec. 30, 2017 USD ($) | Dec. 31, 2016 USD ($) | Dec. 30, 2017 USD ($) unit | Dec. 31, 2016 USD ($)
Segment Reporting [Abstract] |  |  |  |
Number of business units | unit |  |  | 4 |
Segment Reporting Information [Line Items] |  |  |  |
Net Revenues, Before Foreign Exchange Impact | $ 235,904 | $ 233,238 | $ 676,048 | $ 666,667
Effect of exchange rates | (1,861) | (5,397) | (5,677) | (8,617)
Net revenues (reported) | 234,043 | 227,841 | 670,371 | 658,050
Effect of exchange rates | 2,755 | (151) | 1,656 | (790)
Restructuring and turnaround costs | (31,298) | (6,762) | (39,568) | (27,215)
Deal amortization | (6,506) | (6,530) | (19,501) | (20,611)
Legal charges | (3,011) | 0 | (3,011) | 0
Impairment of assets | 0 | (210) | 0 | (1,525)
Operating income | 1,013 | 21,212 | 41,882 | 38,125
Plasma [Member] |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues (reported) | 113,098 | 108,655 | 324,376 | 309,868
Blood Center [Member] |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues (reported) | 74,227 | 76,354 | 211,502 | 221,567
Cell Processing Management [Member] |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues (reported) | 26,829 | 25,918 | 78,929 | 77,949
Hemostasis Management [Member] |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues (reported) | 19,889 | 16,914 | 55,564 | 48,666
United States |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues (reported) | 140,840 | 136,759 | 410,671 | 393,302
Japan |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues (reported) | 17,664 | 22,319 | 49,312 | 58,949
Europe |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues (reported) | 42,189 | 38,892 | 118,544 | 116,865
Asia |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues (reported) | 30,733 | 27,749 | 85,504 | 83,125
Other |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net revenues (reported) | 2,617 | 2,122 | 6,340 | 5,809
Japan |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net Revenues, Before Foreign Exchange Impact | 18,161 | 20,173 | 50,557 | 53,730
EMEA |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net Revenues, Before Foreign Exchange Impact | 47,481 | 49,857 | 134,275 | 141,531
North America Plasma |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net Revenues, Before Foreign Exchange Impact | 86,545 | 83,324 | 249,132 | 235,091
All Other |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Net Revenues, Before Foreign Exchange Impact | 83,717 | 79,884 | 242,084 | 236,315
Operating Segments |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | 83,681 | 71,204 | 229,130 | 212,664
Operating Segments | Japan |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | 8,967 | 9,514 | 23,582 | 24,687
Operating Segments | EMEA |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | 11,423 | 11,143 | 28,233 | 27,996
Operating Segments | North America Plasma |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | 31,740 | 23,125 | 88,026 | 74,443
Operating Segments | All Other |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Operating income | 31,551 | 27,422 | 89,289 | 85,538
Corporate operating expenses |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |
Corporate operating expenses | $ (44,608) | $ (36,339) | $ (126,824) | $ (124,398)

X
- Definition Corporate Operating Expenses + References No definition available. + Details
Name: | hae_CorporateOperatingExpenses
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Effect of Exchange Rate on Revenues + References No definition available. + Details
Name: | hae_EffectofExchangeRateonRevenues
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Effect of Exchange Rates on Operating Income + References No definition available. + Details
Name: | hae_EffectofExchangeRatesonOperatingIncome
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Net Revenues, Before Foreign Exchange Impact + References No definition available. + Details
Name: | hae_NetRevenuesBeforeForeignExchangeImpact
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Restructuring and Turnaround Costs + References No definition available. + Details
Name: | hae_RestructuringandTurnaroundCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_AdjustmentForAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_LegalFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References No definition available. + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=64862545&loc=d3e2921-110230 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585 + Details
Name: | us-gaap_OtherAssetImpairmentCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_SalesRevenueGoodsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ProductOrServiceAxis=hae_PlasmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=hae_BloodCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=hae_CellProcessingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=hae_HemostasisManagementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=us-gaap_AsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=hae_OtherCountryorRegionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_EMEAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_NorthAmericaPlasmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_AmericasBloodCenterandHospitalandAsiaPacificMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |